PARVUS THERAPEUTICS
Parvus Therapeutics is a novel class of therapeutics to reverse autoimmune disease without impairing normal immunity.
PARVUS THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Therapeutics Wellness
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.parvustherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
415-805-8251
Email Addresses:
[email protected]
Technology used in webpage:
SPF Amazon Google Maps API Amazon Route 53 Barracuda Networks
Official Site Inspections
http://www.parvustherapeutics.com
- Host name: s3-website-us-east-1.amazonaws.com
- IP address: 52.216.94.170
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Parvus Therapeutics"
Parvus Therapeutics Inc.
At Parvus, we are developing proprietary novel pMHC nanomedicine drug candidates which trigger in vivo generation of antigen-specific regulatory T cells (Tregs) with the potential to halt …See details»
Company - Parvus Therapeutics Inc.
About Parvus At Parvus, we are developing a pipeline of novel proprietary pMHC nanomedicine drug candidates (a.k.a. NavacimsTM) which trigger endogenous generation of regulatory T cells (Tregs) to provide organ specific …See details»
Parvus Therapeutics - Crunchbase Company Profile
Parvus Therapeutics is a novel class of therapeutics to reverse autoimmune disease without impairing normal immunity.See details»
Parvus Therapeutics Inc - LinkedIn
Parvus Therapeutics Inc | 2,912 followers on LinkedIn. Reverse autoimmune disease without impairing normal immunity | Parvus Therapeutics Inc. is a privately held biopharmaceutical company ...See details»
Parvus Therapeutics Inc Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Parvus Therapeutics Inc of Calgary, AB. Get the latest business insights from Dun & Bradstreet.See details»
Parvus Therapeutics Company Profile | Management and
Find contact information for Parvus Therapeutics. Learn about their Pharmaceuticals, Manufacturing market share, competitors, and Parvus Therapeutics's email format.See details»
Parvus Therapeutics U.S., Inc. Company Profile - PR.com
Parvus Therapeutics Inc. is a privately held biopharmaceutical company developing Navacims™, a platform technology based on foundational research published in 2016 (Nature 530:434), to …See details»
Parvus Therapeutics - VentureRadar
"Parvus is pioneering a novel class of disease-modifying therapeutics – Navacims™ – that are designed to reverse autoimmune disease by selectively blunting the action of autoimmunity …See details»
Parvus Therapeutics: Revenue, Worth, Valuation & Competitors 2025
About Parvus Therapeutics Parvus Therapeutics is a Biotech related company based in South San Francisco with 23 employees an estimated revenue of $3.6M, and. It has 10 competitors …See details»
Parvus Therapeutics Announces Key Executive and Board of …
Jul 16, 2019 Parvus Therapeutics Inc. is a privately-held biopharmaceutical company engaged in the development and commercialization of Navacim therapeutics targeting autoimmune and …See details»
Parvus Therapeutics 2025 Company Profile: Valuation, …
Information on valuation, funding, cap tables, investors, and executives for Parvus Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Parvus Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
About Parvus Therapeutics Inc. Parvus is a private clinical-stage company developing proprietary peptide-major histocompatibility complex (pMHC) nanomedicine drug candidates designed to …See details»
Parvus Therapeutics - VentureRadar
Parvus is pioneering a novel class of disease-modifying therapeutics – Navacims™ – that are designed to reverse autoimmune disease by selectively blunting the action of autoimmunity …See details»
Parvus Therapeutics - Craft
Parvus Therapeutics has 5 employees at their 1 location. See insights on Parvus Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
Parvus Therapeutics Enters into Worldwide Collaboration and …
May 16, 2019 About Parvus Therapeutics Inc. Parvus Therapeutics Inc. is a privately-held biopharmaceutical company engaged in the development and commercialization of Navacim …See details»
Genentech signs deal with Parvus to tackle inflammatory diseases
May 17, 2019 Canada’s Parvus Therapeutics has signed a deal with Roche’s Genentech unit to develop, manufacture and market drugs for inflammatory bowel disease, autoimmune liver …See details»
Parvus Therapeutics Announces CEO, Senior Executive, and Board …
Jul 6, 2021 Parvus Therapeutics, a biopharmaceutical company focused on the development of medicines using the proprietary platform-based, disease-specific immunoregulator, …See details»
Resilience and Parvus Team Up for PVT401 Development
Jan 8, 2025 Resilience collaborates with Parvus Therapeutics to develop PVT401, targeting autoimmune diseases. This partnership aims to innovate therapies for patients in need.See details»
Parvus Therapeutics and Ardena Enter Agreement for Tech …
Nov 19, 2021 Today Parvus announced it has entered into an agreement with Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organization (CDMO), for …See details»
Pipeline - Parvus Therapeutics Inc.
Parvus’ pipeline programs address a broad range of autoimmune diseases with compelling unmet needs, including Type 1 diabetes (T1D), inflammatory bowel disease (IBD), celiac disease, …See details»